| 000 | 01706 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515100830.0 | ||
| 264 | 0 | _c20080418 | |
| 008 | 200804s 0 0 eng d | ||
| 022 | _a0091-2700 | ||
| 024 | 7 |
_a10.1177/0091270007310379 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGengo, Francis M | |
| 245 | 0 | 0 |
_aEffects of ibuprofen on the magnitude and duration of aspirin's inhibition of platelet aggregation: clinical consequences in stroke prophylaxis. _h[electronic resource] |
| 260 |
_bJournal of clinical pharmacology _cJan 2008 |
||
| 300 |
_a117-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xpharmacology |
| 650 | 0 | 4 |
_aAspirin _xpharmacology |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIbuprofen _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aSingle-Blind Method |
| 650 | 0 | 4 |
_aStroke _xetiology |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aRubin, Lisa | |
| 700 | 1 | _aRobson, Matthew | |
| 700 | 1 | _aRainka, Michelle | |
| 700 | 1 | _aGengo, Michael F | |
| 700 | 1 | _aMager, Donald E | |
| 700 | 1 | _aBates, Vernice | |
| 773 | 0 |
_tJournal of clinical pharmacology _gvol. 48 _gno. 1 _gp. 117-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/0091270007310379 _zAvailable from publisher's website |
| 999 |
_c17606588 _d17606588 |
||